Filtered By:
Specialty: Drugs & Pharmacology
Procedure: Dialysis
Countries: Iran Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
The Impact of Intravenous Iron Supplementation on Hematinic Parameters and Erythropoietin Requirements in Hemodialysis Patients
ConclusionHigh-dose intravenous iron (400 mg/week) can reduce the mean dose of rhEPO requirements and increase the TSAT index over a period of 6 months in hemodialysis patients. High-dose IV iron administration can decrease cardiovascular events in hemodialysis patients with iron deficiency anemia.
Source: Advances in Therapy - July 12, 2021 Category: Drugs & Pharmacology Source Type: research
